Does Option Care Health (NASDAQ:OPCH) Deserve A Spot On Your Watchlist?
Investors are often guided by the idea of discovering 'the next big thing', even if that means buying 'story stocks' without any revenue, let alone profit. But the reality is that when a company loses money each year, for long enough, its investors will usually take their share of those losses. Loss making companies can act like a sponge for capital - so investors should be cautious that they're not throwing good money after bad.
In contrast to all that, many investors prefer to focus on companies like Option Care Health (NASDAQ:OPCH), which has not only revenues, but also profits. While this doesn't necessarily speak to whether it's undervalued, the profitability of the business is enough to warrant some appreciation - especially if its growing.
See our latest analysis for Option Care Health
Option Care Health's Improving Profits
In the last three years Option Care Health's earnings per share took off; so much so that it's a bit disingenuous to use these figures to try and deduce long term estimates. As a result, we'll zoom in on growth over the last year, instead. Option Care Health's EPS skyrocketed from US$0.99 to US$1.45, in just one year; a result that's bound to bring a smile to shareholders. That's a fantastic gain of 47%.
It's often helpful to take a look at earnings before interest and tax (EBIT) margins, as well as revenue growth, to get another take on the quality of the company's growth. While we note Option Care Health achieved similar EBIT margins to last year, revenue grew by a solid 9.4% to US$4.2b. That's progress.
You can take a look at the company's revenue and earnings growth trend, in the chart below. For finer detail, click on the image.
Fortunately, we've got access to analyst forecasts of Option Care Health's future profits. You can do your own forecasts without looking, or you can take a peek at what the professionals are predicting.
Are Option Care Health Insiders Aligned With All Shareholders?
It's said that there's no smoke without fire. For investors, insider buying is often the smoke that indicates which stocks could set the market alight. This view is based on the possibility that stock purchases signal bullishness on behalf of the buyer. However, small purchases are not always indicative of conviction, and insiders don't always get it right.
We do note that, in the last year, insiders sold US$49k worth of shares. But that's far less than the US$2.1m insiders spent purchasing stock. We find this encouraging because it suggests they are optimistic about Option Care Health'sfuture. Zooming in, we can see that the biggest insider purchase was by Independent Non Executive Chairman of the Board Harry M. Kraemer for US$1.9m worth of shares, at about US$34.63 per share.